Europe's largest lab group Synlab forecasts that it will see 3+% of annual organic growth over the mid-term, saying that testing will remain a core part of pandemic control. Other lab groups clearly agree with that punt, with news that smaller rival Amedes reportedly is preparing for sale.
The post Amedes for sale as Synlab forecasts future organic growth to settle about 3% appeared first on Healthcare Business International.